IXICO plc (FRA:PYPB)

Germany · Delayed Price · Currency is EUR

0.0795

0.00 (0.00%)

Last updated: Aug 27, 2026, 8:09 AM CET

-39.77% (1Y)

Market Cap	19.71M +49.8%
Revenue (ttm)	8.33M +13.0%
Net Income	-2.08M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0795
Previous Close	0.0795
Day's Range	0.0795 - 0.0795
52-Week Range	0.0655 - 0.1530
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 1, 2026

About IXICO

IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services. It also provides imaging contract research organization solutions, including imaging biomarkers, such as radiological reads, volumetric MRI, PET and SPECT, and advanced MRI... [Read more]

Industry Medicinal Chemicals and Botanical Products

CEO Bram Goorden

Employees 79

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol PYPB

Financial Performance

In fiscal year 2025, IXICO's revenue was 6.53 million, an increase of 13.32% compared to the previous year's 5.77 million. Losses were -1.65 million, -17.49% less than in 2024.

Financial numbers in GBP Financial Statements